Trial site
Mary Crowley Cancer Research Center
- 7running trials
- 7closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Lung cancer7 trials
- Ovarian cancer4 trials
- Bladder cancer3 trials
- Colorectal cancer3 trials
- Pancreatic cancer3 trials
- Cervical cancer2 trials
- Head and neck cancer2 trials
- Liver and biliary tract cancer2 trials
- Chronic lymphocytic leukaemia1 trial
- Diffuse large B-cell lymphoma1 trial
- Endometrial cancer1 trial
- Follicular lymphoma1 trial
- and 6 more
- Phase
- Phase 16 trials
- Phase 1/24 trials
- Phase 23 trials
- Phase 31 trial
- Status
- Completed7 trials
- Active, not recruiting4 trials
- Recruiting3 trials
- Lead sponsor
- Boehringer Ingelheim2 trials
- Eli Lilly and Company2 trials
- Agenus Inc.1 trial
- Astellas Pharma Global Development, Inc.1 trial
- BicycleTx Limited1 trial
- and 7 more
Running trials
Recruiting
Recruiting
Recruiting
Active, not recruiting
Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies
Active, not recruiting
Active, not recruiting
Study of Combined SGT-53 Plus Gemcitabine/Nab-Paclitaxel for Metastatic Pancreatic Cancer
Active, not recruiting
A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Colorectal cancer1 recruiting
- Lung cancer1 recruiting
- Ovarian cancer1 recruiting
Closed trials
Recruiting
Completed
Completed
Hepcidin Mimetic in Patients With Polycythemia Vera (REVIVE)
Completed
Anti-CD137 and Anti-CTLA-4 Monoclonal Antibody in Patients With Advanced Cancer
Completed
A Study of NBF-006 in Non-Small Cell Lung, Pancreatic, or Colorectal Cancer
Completed
A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL
Completed
Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination With Pembrolizumab
Site data: ClinicalTrials.govUpdated 14 Nov 2026